カテゴリー： Market Monitor Global, 世界, 医療/バイオ

乾癬性関節炎治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Psoriatic Arthritis Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8617 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Psoriatic Arthritis Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの乾癬性関節炎治療薬市場規模と予測を収録しています。・世界の乾癬性関節炎治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の乾癬性関節炎治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の乾癬性関節炎治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「TNF阻害剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

乾癬性関節炎治療薬のグローバル主要企業は、Abbvie、 Janssen、 Amgen、 Pfizer、 Eli-Lilly、 Celgeneなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、乾癬性関節炎治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の乾癬性関節炎治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の乾癬性関節炎治療薬市場：タイプ別市場シェア、2022年
・TNF阻害剤、PDE4阻害剤、インターロイキン阻害剤、その他

世界の乾癬性関節炎治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の乾癬性関節炎治療薬市場：用途別市場シェア、2022年
・軽度乾癬性関節炎、中等度乾癬性関節炎、重度乾癬性関節炎

世界の乾癬性関節炎治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の乾癬性関節炎治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における乾癬性関節炎治療薬のグローバル売上、2018年-2023年
・主要企業における乾癬性関節炎治療薬のグローバル売上シェア、2022年
・主要企業における乾癬性関節炎治療薬のグローバル販売量、2018年-2023年
・主要企業における乾癬性関節炎治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbvie、 Janssen、 Amgen、 Pfizer、 Eli-Lilly、 Celgene

*************************************************************

・調査・分析レポートの概要
乾癬性関節炎治療薬市場の定義
市場セグメント
世界の乾癬性関節炎治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の乾癬性関節炎治療薬市場規模
世界の乾癬性関節炎治療薬市場規模：2022年 VS 2029年
世界の乾癬性関節炎治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの乾癬性関節炎治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の乾癬性関節炎治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：TNF阻害剤、PDE4阻害剤、インターロイキン阻害剤、その他
乾癬性関節炎治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：軽度乾癬性関節炎、中等度乾癬性関節炎、重度乾癬性関節炎
乾癬性関節炎治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別乾癬性関節炎治療薬市場規模 2022年と2029年
地域別乾癬性関節炎治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbvie、 Janssen、 Amgen、 Pfizer、 Eli-Lilly、 Celgene
...

This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Drugs. This report contains market size and forecasts of Psoriatic Arthritis Drugs in global, including the following market information:
Global Psoriatic Arthritis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Psoriatic Arthritis Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Psoriatic Arthritis Drugs companies in 2022 (%)
The global Psoriatic Arthritis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
TNF Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psoriatic Arthritis Drugs include Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly and Celgene, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psoriatic Arthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriatic Arthritis Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Psoriatic Arthritis Drugs Market Segment Percentages, by Type, 2022 (%)
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Global Psoriatic Arthritis Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Psoriatic Arthritis Drugs Market Segment Percentages, by Application, 2022 (%)
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Global Psoriatic Arthritis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Psoriatic Arthritis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psoriatic Arthritis Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Psoriatic Arthritis Drugs revenues share in global market, 2022 (%)
Key companies Psoriatic Arthritis Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Psoriatic Arthritis Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psoriatic Arthritis Drugs, market overview.
Chapter 2: Global Psoriatic Arthritis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psoriatic Arthritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Psoriatic Arthritis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Psoriatic Arthritis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psoriatic Arthritis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psoriatic Arthritis Drugs Overall Market Size
2.1 Global Psoriatic Arthritis Drugs Market Size: 2022 VS 2029
2.2 Global Psoriatic Arthritis Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Psoriatic Arthritis Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Psoriatic Arthritis Drugs Players in Global Market
3.2 Top Global Psoriatic Arthritis Drugs Companies Ranked by Revenue
3.3 Global Psoriatic Arthritis Drugs Revenue by Companies
3.4 Global Psoriatic Arthritis Drugs Sales by Companies
3.5 Global Psoriatic Arthritis Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Psoriatic Arthritis Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Psoriatic Arthritis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Psoriatic Arthritis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Psoriatic Arthritis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Psoriatic Arthritis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Psoriatic Arthritis Drugs Market Size Markets, 2022 & 2029
4.1.2 TNF Inhibitors
4.1.3 PDE4 Inhibitors
4.1.4 Interleukin Blockers
4.1.5 Other
4.2 By Type – Global Psoriatic Arthritis Drugs Revenue & Forecasts
4.2.1 By Type – Global Psoriatic Arthritis Drugs Revenue, 2018-2023
4.2.2 By Type – Global Psoriatic Arthritis Drugs Revenue, 2024-2029
4.2.3 By Type – Global Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Psoriatic Arthritis Drugs Sales & Forecasts
4.3.1 By Type – Global Psoriatic Arthritis Drugs Sales, 2018-2023
4.3.2 By Type – Global Psoriatic Arthritis Drugs Sales, 2024-2029
4.3.3 By Type – Global Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Psoriatic Arthritis Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Psoriatic Arthritis Drugs Market Size, 2022 & 2029
5.1.2 Mild Psoriatic Arthritis
5.1.3 Moderate Psoriatic Arthritis
5.1.4 Severe Psoriatic Arthritis
5.2 By Application – Global Psoriatic Arthritis Drugs Revenue & Forecasts
5.2.1 By Application – Global Psoriatic Arthritis Drugs Revenue, 2018-2023
5.2.2 By Application – Global Psoriatic Arthritis Drugs Revenue, 2024-2029
5.2.3 By Application – Global Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Psoriatic Arthritis Drugs Sales & Forecasts
5.3.1 By Application – Global Psoriatic Arthritis Drugs Sales, 2018-2023
5.3.2 By Application – Global Psoriatic Arthritis Drugs Sales, 2024-2029
5.3.3 By Application – Global Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Psoriatic Arthritis Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Psoriatic Arthritis Drugs Market Size, 2022 & 2029
6.2 By Region – Global Psoriatic Arthritis Drugs Revenue & Forecasts
6.2.1 By Region – Global Psoriatic Arthritis Drugs Revenue, 2018-2023
6.2.2 By Region – Global Psoriatic Arthritis Drugs Revenue, 2024-2029
6.2.3 By Region – Global Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Psoriatic Arthritis Drugs Sales & Forecasts
6.3.1 By Region – Global Psoriatic Arthritis Drugs Sales, 2018-2023
6.3.2 By Region – Global Psoriatic Arthritis Drugs Sales, 2024-2029
6.3.3 By Region – Global Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Psoriatic Arthritis Drugs Revenue, 2018-2029
6.4.2 By Country – North America Psoriatic Arthritis Drugs Sales, 2018-2029
6.4.3 US Psoriatic Arthritis Drugs Market Size, 2018-2029
6.4.4 Canada Psoriatic Arthritis Drugs Market Size, 2018-2029
6.4.5 Mexico Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Psoriatic Arthritis Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Psoriatic Arthritis Drugs Sales, 2018-2029
6.5.3 Germany Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5.4 France Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5.5 U.K. Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5.6 Italy Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5.7 Russia Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Psoriatic Arthritis Drugs Market Size, 2018-2029
6.5.9 Benelux Psoriatic Arthritis Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Psoriatic Arthritis Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Psoriatic Arthritis Drugs Sales, 2018-2029
6.6.3 China Psoriatic Arthritis Drugs Market Size, 2018-2029
6.6.4 Japan Psoriatic Arthritis Drugs Market Size, 2018-2029
6.6.5 South Korea Psoriatic Arthritis Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Psoriatic Arthritis Drugs Market Size, 2018-2029
6.6.7 India Psoriatic Arthritis Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Psoriatic Arthritis Drugs Revenue, 2018-2029
6.7.2 By Country – South America Psoriatic Arthritis Drugs Sales, 2018-2029
6.7.3 Brazil Psoriatic Arthritis Drugs Market Size, 2018-2029
6.7.4 Argentina Psoriatic Arthritis Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Psoriatic Arthritis Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Psoriatic Arthritis Drugs Sales, 2018-2029
6.8.3 Turkey Psoriatic Arthritis Drugs Market Size, 2018-2029
6.8.4 Israel Psoriatic Arthritis Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Psoriatic Arthritis Drugs Market Size, 2018-2029
6.8.6 UAE Psoriatic Arthritis Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Psoriatic Arthritis Drugs Major Product Offerings
7.1.4 Abbvie Psoriatic Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Abbvie Key News & Latest Developments
7.2 Janssen
7.2.1 Janssen Company Summary
7.2.2 Janssen Business Overview
7.2.3 Janssen Psoriatic Arthritis Drugs Major Product Offerings
7.2.4 Janssen Psoriatic Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Janssen Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Psoriatic Arthritis Drugs Major Product Offerings
7.3.4 Amgen Psoriatic Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Psoriatic Arthritis Drugs Major Product Offerings
7.4.4 Pfizer Psoriatic Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Eli-Lilly
7.5.1 Eli-Lilly Company Summary
7.5.2 Eli-Lilly Business Overview
7.5.3 Eli-Lilly Psoriatic Arthritis Drugs Major Product Offerings
7.5.4 Eli-Lilly Psoriatic Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Eli-Lilly Key News & Latest Developments
7.6 Celgene
7.6.1 Celgene Company Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Psoriatic Arthritis Drugs Major Product Offerings
7.6.4 Celgene Psoriatic Arthritis Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Celgene Key News & Latest Developments
8 Global Psoriatic Arthritis Drugs Production Capacity, Analysis
8.1 Global Psoriatic Arthritis Drugs Production Capacity, 2018-2029
8.2 Psoriatic Arthritis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Psoriatic Arthritis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Psoriatic Arthritis Drugs Supply Chain Analysis
10.1 Psoriatic Arthritis Drugs Industry Value Chain
10.2 Psoriatic Arthritis Drugs Upstream Market
10.3 Psoriatic Arthritis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Psoriatic Arthritis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Psoriatic Arthritis Drugs in Global Market
Table 2. Top Psoriatic Arthritis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Psoriatic Arthritis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Psoriatic Arthritis Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Psoriatic Arthritis Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Psoriatic Arthritis Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Psoriatic Arthritis Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Psoriatic Arthritis Drugs Product Type
Table 9. List of Global Tier 1 Psoriatic Arthritis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psoriatic Arthritis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Psoriatic Arthritis Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Psoriatic Arthritis Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Psoriatic Arthritis Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Psoriatic Arthritis Drugs Sales (K MT), 2024-2029
Table 16. By Application – Global Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Psoriatic Arthritis Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Psoriatic Arthritis Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Psoriatic Arthritis Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Psoriatic Arthritis Drugs Sales (K MT), 2024-2029
Table 21. By Region – Global Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Psoriatic Arthritis Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Psoriatic Arthritis Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Psoriatic Arthritis Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Psoriatic Arthritis Drugs Sales (K MT), 2024-2029
Table 26. By Country - North America Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Psoriatic Arthritis Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Psoriatic Arthritis Drugs Sales, (K MT), 2024-2029
Table 30. By Country - Europe Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Psoriatic Arthritis Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Psoriatic Arthritis Drugs Sales, (K MT), 2024-2029
Table 34. By Region - Asia Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Psoriatic Arthritis Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Psoriatic Arthritis Drugs Sales, (K MT), 2024-2029
Table 38. By Country - South America Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Psoriatic Arthritis Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Psoriatic Arthritis Drugs Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Psoriatic Arthritis Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Psoriatic Arthritis Drugs Sales, (K MT), 2024-2029
Table 46. Abbvie Company Summary
Table 47. Abbvie Psoriatic Arthritis Drugs Product Offerings
Table 48. Abbvie Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Abbvie Key News & Latest Developments
Table 50. Janssen Company Summary
Table 51. Janssen Psoriatic Arthritis Drugs Product Offerings
Table 52. Janssen Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Janssen Key News & Latest Developments
Table 54. Amgen Company Summary
Table 55. Amgen Psoriatic Arthritis Drugs Product Offerings
Table 56. Amgen Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Amgen Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Psoriatic Arthritis Drugs Product Offerings
Table 60. Pfizer Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Eli-Lilly Company Summary
Table 63. Eli-Lilly Psoriatic Arthritis Drugs Product Offerings
Table 64. Eli-Lilly Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Eli-Lilly Key News & Latest Developments
Table 66. Celgene Company Summary
Table 67. Celgene Psoriatic Arthritis Drugs Product Offerings
Table 68. Celgene Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Celgene Key News & Latest Developments
Table 70. Psoriatic Arthritis Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 71. Global Psoriatic Arthritis Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Psoriatic Arthritis Drugs Production by Region, 2018-2023 (K MT)
Table 73. Global Psoriatic Arthritis Drugs Production by Region, 2024-2029 (K MT)
Table 74. Psoriatic Arthritis Drugs Market Opportunities & Trends in Global Market
Table 75. Psoriatic Arthritis Drugs Market Drivers in Global Market
Table 76. Psoriatic Arthritis Drugs Market Restraints in Global Market
Table 77. Psoriatic Arthritis Drugs Raw Materials
Table 78. Psoriatic Arthritis Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Psoriatic Arthritis Drugs Downstream
Table 80. Psoriatic Arthritis Drugs Downstream Clients in Global Market
Table 81. Psoriatic Arthritis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Psoriatic Arthritis Drugs Segment by Type in 2022
Figure 2. Psoriatic Arthritis Drugs Segment by Application in 2022
Figure 3. Global Psoriatic Arthritis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psoriatic Arthritis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Psoriatic Arthritis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Psoriatic Arthritis Drugs Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Psoriatic Arthritis Drugs Revenue in 2022
Figure 9. By Type - Global Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Psoriatic Arthritis Drugs Price (USD/MT), 2018-2029
Figure 13. By Application - Global Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Psoriatic Arthritis Drugs Price (USD/MT), 2018-2029
Figure 17. By Region - Global Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Psoriatic Arthritis Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 23. US Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 28. Germany Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 37. China Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Psoriatic Arthritis Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Psoriatic Arthritis Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Psoriatic Arthritis Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Psoriatic Arthritis Drugs Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Psoriatic Arthritis Drugs by Region, 2022 VS 2029
Figure 54. Psoriatic Arthritis Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 乾癬性関節炎治療薬の世界市場見通し2023年-2029年(Psoriatic Arthritis Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

乾癬性関節炎治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp